TrialClinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis2018

Factors That Determine the Prothrombin Time in Patients With Atrial Fibrillation Receiving Rivaroxaban.

Jen-Hung Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.